US-based diagnostics technology developer Karius has raised $50m in a series A round from a consortium that included internet company Tencent, CNBC reported on Saturday.
The round also featured venture capital firms Khosla Ventures, Data Collective, Innovation Endeavors and Lightspeed Venture Partners.
Karius has developed a test that identifies the source of a patient’s infection, revealing whether the cause is bacterial, viral or fungal by analysing fragments of DNA in their blood.
The technology is currently able to detect more…
